Skip to content

Author

Poornima Priyadarshini

We have 4 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Targeting tau acetylation in Alzheimer's disease: Molecular mechanisms, pathological consequences, and therapeutic opportunities of dietary phytochemicals.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by cognitive decline, synaptic dysfunction, and neuronal loss. Emerging evidence identifies tau acetylation as a crucial post-translational modification that contribute significantly to tauopathies associated pathology in AD. Aberrant ta...

K. Basavaraju, Poornima Priyadarshini · 0 citations
2026

Synergetic inhibition of deubiquitinases and acetyltransferases to regulate tau acetylation and aggregation in SH-SY5Y cell line model of Alzheimer's disease.

The development of standardized cell culture models in the SH-SY5Y neuronal system will be crucial to evaluating the therapeutic potential of this synergetic inhibition strategy, thereby restoring ubiquitination and promoting tau degradation.

Basavaraju K. C., Harshitha D. K., Poornima Priyadarshini · 0 citations
Review 2026

Bioenergetic impairment-induced Tau acetylation: Converging pathways in Alzheimer's disease.

Understanding the metabolic pathways that drive tau acetylation may offer new therapeutic targets aimed at restoring neuronal energy balance, re-establishing acetylation homeostasis, and potentially slowing the progression of AD.

Basavaraju K. C., Poornima Priyadarshini · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.